These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application. Kamarulzaman EE; Vanderesse R; Gazzali AM; Barberi-Heyob M; Boura C; Frochot C; Shawkataly O; Aubry A; Wahab HA J Biomol Struct Dyn; 2017 Jan; 35(1):26-45. PubMed ID: 26766582 [TBL] [Abstract][Full Text] [Related]
4. Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine. Puszko AK; Sosnowski P; Raynaud F; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32183142 [TBL] [Abstract][Full Text] [Related]
5. Binding of a C-end rule peptide to the neuropilin-1 receptor: a molecular modeling approach. Haspel N; Zanuy D; Nussinov R; Teesalu T; Ruoslahti E; Aleman C Biochemistry; 2011 Mar; 50(10):1755-62. PubMed ID: 21247217 [TBL] [Abstract][Full Text] [Related]
6. Biodistribution and evaluation of Dong P; Cai H; Chen L; Li Y; Yuan C; Wu X; Shen G; Zhou H; Zhang W; Li L Contrast Media Mol Imaging; 2016 Nov; 11(6):467-474. PubMed ID: 27527756 [TBL] [Abstract][Full Text] [Related]
7. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Teesalu T; Sugahara KN; Kotamraju VR; Ruoslahti E Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16157-62. PubMed ID: 19805273 [TBL] [Abstract][Full Text] [Related]
8. Identification of Four New Chemical Series of Small Drug-Like Natural Products as Potential Neuropilin-1 Inhibitors by Structure-Based Virtual Screening: Pharmacophore-Based Molecular Docking and Dynamics Simulation. Sabki A; Khelifi L; Kameli A; Baali S Chem Biodivers; 2023 Mar; 20(3):e202200933. PubMed ID: 36799050 [TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability. Baek DS; Kim JH; Kim YJ; Kim YS Mol Pharm; 2018 Feb; 15(2):394-402. PubMed ID: 29232521 [TBL] [Abstract][Full Text] [Related]
10. Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma. Wu HB; Wang Z; Wang QS; Han YJ; Wang M; Zhou WL; Li HS PLoS One; 2015; 10(9):e0137676. PubMed ID: 26398657 [TBL] [Abstract][Full Text] [Related]
11. The penetrating properties of the tumor homing peptide LyP-1 in model lipid membranes. Ciobanasu C; Dragomir I; Apetrei A J Pept Sci; 2019 Mar; 25(3):e3145. PubMed ID: 30588706 [TBL] [Abstract][Full Text] [Related]
13. Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor. Zanuy D; Kotla R; Nussinov R; Teesalu T; Sugahara KN; Alemán C; Haspel N J Struct Biol; 2013 May; 182(2):78-86. PubMed ID: 23462097 [TBL] [Abstract][Full Text] [Related]
14. Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel. Hu Q; Gao X; Gu G; Kang T; Tu Y; Liu Z; Song Q; Yao L; Pang Z; Jiang X; Chen H; Chen J Biomaterials; 2013 Jul; 34(22):5640-50. PubMed ID: 23639530 [TBL] [Abstract][Full Text] [Related]
15. Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1. Novoa A; Pellegrini-Moïse N; Bechet D; Barberi-Heyob M; Chapleur Y Bioorg Med Chem; 2010 May; 18(9):3285-98. PubMed ID: 20363638 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship study of tetrapeptide inhibitors of the Vascular Endothelial Growth Factor A binding to Neuropilin-1. Tymecka D; Lipiński PFJ; Fedorczyk B; Puszko A; Wileńska B; Perret GY; Misicka A Peptides; 2017 Aug; 94():25-32. PubMed ID: 28627371 [TBL] [Abstract][Full Text] [Related]
17. tLyP-1 Peptide Functionalized Human H Chain Ferritin for Targeted Delivery of Paclitaxel. Ma Y; Li R; Dong Y; You C; Huang S; Li X; Wang F; Zhang Y Int J Nanomedicine; 2021; 16():789-802. PubMed ID: 33568906 [TBL] [Abstract][Full Text] [Related]